Randomized phase III trial of erlotinib versus docetaxel in patients with advanced squamous cell non-small cell lung cancer failing first-line platinum-based doublet chemotherapy stratified by VeriStrat® Good versus VeriStrat® Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial.